Clinical TrialID 6647
Safety and Efficacy Study of Photopheresis Plus Standard Therapy to Treat Chronic Graft-versus-Host Disease
NCT00054613
Graft-versus-Host Disease
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 6647
- Evidence Id
- 6647
- Core Evidence Id
- 6647
- Source Clinical Trial Id
- 6633
- Herb2 Clinical Trial Id
- HBCT006633
- Nct Id
- NCT00054613
- Title
- Safety and Efficacy Study of Photopheresis Plus Standard Therapy to Treat Chronic Graft-versus-Host Disease
- Status
- Completed
- Phase
- Phase 2
- Study Result
- No
- Study Condition
- Graft-versus-Host Disease
- Study Type
- Interventional
- Study Design
- Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE|Primary Purpose: TREATMENT
- Intervention
- DRUG: Methoxsalen|PROCEDURE: Extracorporeal Photopheresis
- Intervention Allocation
- Randomized
- Intervention Model
- Parallel
- Intervention Mask
- Single
- Intervention Purpose
- Treatment
- Gender
- All
- Age
- Child, Adult, Older_Adult
- Enrollment
- 72
- Outcome Measure
- Sponsor Collaborator
- Mallinckrodt
- Funded By
- INDUSTRY
- Location
- University of Arkansas for Medical Sciences, Little Rock, Arkansas, 72205, United States|University of Florida, Gainesville, Florida, 32610, United States|Rush Presbyterian - St. Lukes Medical Center, Chicago, Illinois, 60612, United States|University of Chicago, Chicago, Illinois, 60637, United States|Tufts New England Medical Center, Boston, Massachusetts, 02111, United States|Brigham and Womens, Boston, Massachusetts, 02115, United States|University of Michigan, Ann Arbor, Michigan, 48109-0914, United States|Kansas City Cancer Center, Kansas City, Missouri, 64111, United States|University of Nebraska, Omaha, Nebraska, 68198-7680, United States|Jewish Hospital, Cincinnati, Ohio, 45236, United States|Fred Hutchinson Cancer Research Center, Seattle, Washington, 19024, United States|St. Vincent's Hospital, Darlinghurst, New South Wales, 2010, Australia|Peter MacCallum, East Melbourne, Australia|Alfred Hospital, Melbourne, Australia|Royal Melbourne Hospital, Parkville, 3050, Australia|General Hospital of Vienna, Vienna, A-1090, Austria|Hopital Edouard Herriot, Lyon Cedex 03, 69437, France|Hopital Pitie-Salpetriere, Paris, F-75013, France|University of Dresden, Dresden, D-01307, Germany|Universitatis Hautklinik, Essen, 45122, Germany|Universitatsklinikum Leipzig AOR, Leipzig, D-04103, Germany|Ludwig-Maximilians-Universitaet Muenchen, Munchen, D-81377, Germany|Careggi Hospital, Florence, 1-50134, Italy|San Martino Hospital, Genova, 16132, Italy|Instituto Portugues de Oncologia de Francisco Gentil, Lisboa, 1099-023, Portugal|Klinika hematologie a transfuziologie FN, Bratislava, 81103, Slovakia|Hospital dela Santa Creu i Sant Pau. Universitat Autonoma de Barcelona, Barcelona, E-08025, Spain|Kantonsspital Basel, Basel, CH-4031, Switzerland|Ankara University Medical School, Altındağ, Ankara, 6100, Turkey|Rotherham General Hospital, Rotherham, Yorkshire, S60 2UD, United Kingdom|Glasgow Royal Infirmary, Glasgow, G4 OS4, United Kingdom
- Other Id
- GvHD-SK1
- Start Date
- 2002-06
- Primary Completion Date
- Completion Date
- 2004-03
- First Posted
- 2003-02-06
- Results First Posted
- Last Update Posted
- 2017-08-16
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT00054613
- Title Cn
- Title En
- Safety and Efficacy Study of Photopheresis Plus Standard Therapy to Treat Chronic Graft-versus-Host Disease
- Bilingual Status
- semi_complete